Literature DB >> 25820335

Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma.

Michael Hahn1, Paul Schnitzler2, Brunhilde Schweiger3, Christina Kunz4, Anthony D Ho1, Hartmut Goldschmidt1, Michael Schmitt5.   

Abstract

Entities:  

Keywords:  infectious diseases; influenza; multiple myeloma; vaccination; virus

Mesh：

Substances：

Year:  2015        PMID： 25820335      PMCID： PMC4486243          DOI： 10.3324/haematol.2014.116772

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

Review 1.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

2.  Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial.

Authors:  Ralf Dikow; Isabella Eckerle; Dorothea Ksoll-Rudek; Heidrun Hampel; Vedat Schwenger; Martin Zeier; Paul Schnitzler; Claudia Sommerer
Journal:  Am J Kidney Dis       Date:  2011-02-23       Impact factor: 8.860

Review 3.  The immune response to influenza infection.

Authors:  G L Ada; P D Jones
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

Review 4.  Immunity to influenza in man.

Authors:  R B Couch; J A Kasel
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

5.  Influenza immunization of adult patients with malignant diseases.

Authors:  D W Ortbals; H Liebhaber; C A Presant; A L Van Amburg; J Y Lee
Journal:  Ann Intern Med       Date:  1977-11       Impact factor: 25.391

6.  The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.

Authors:  Dan Engelhard; Zichria Zakay-Rones; Michael Y Shapira; Igor Resnick; Diana Averbuch; Sigal Grisariu; Lillian Dray; Esther Djian; Nurith Strauss-Liviatan; Itamar Grotto; Dana G Wolf; Reuven Or
Journal:  Vaccine       Date:  2011-01-07       Impact factor: 3.641

7.  Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Authors:  Markus Bickel; Nils von Hentig; Imke Wieters; Pavel Khaykin; Gabi Nisius; Annette Haberl; Christoph Stephan; Eva Herrmann; Hans W Doerr; Hans Reinhard Brodt; Regina Allwinn
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079

8.  Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation.

Authors:  Saskia Gueller; Regina Allwinn; Sabine Mousset; Hans Martin; Imke Wieters; Eva Herrmann; Hubert Serve; Markus Bickel; Gesine Bug
Journal:  Biol Blood Marrow Transplant       Date:  2011-02-13       Impact factor: 5.742

9.  Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients.

Authors:  D Engelhard; A Nagler; I Hardan; A Morag; M Aker; H Baciu; N Strauss; G Parag; E Naparstek; Z Ravid
Journal:  Bone Marrow Transplant       Date:  1993-01       Impact factor: 5.483

10.  Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma.

Authors:  J D Robertson; K Nagesh; S N Jowitt; M Dougal; H Anderson; K Mutton; M Zambon; J H Scarffe
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640
View more
  13 in total

1.  Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial.

Authors:  Andrew R Branagan; Eamon Duffy; Randy A Albrecht; Dennis L Cooper; Stuart Seropian; Terri L Parker; Geliang Gan; Fangyong Li; Daniel Zelterman; Chandra Sekhar Boddupalli; Lin Zhang; Rakesh Verma; Thomas M Ferencz; Madhav V Dhodapkar
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-03-07

2.  Effect of daratumumab on normal plasma cells, polyclonal immunoglobulin levels, and vaccination responses in extensively pre-treated multiple myeloma patients.

Authors:  Kristine A Frerichs; Patricia W C Bosman; Jeroen F van Velzen; Pieter L A Fraaij; Marion P G Koopmans; Guus F Rimmelzwaan; Inger S Nijhof; Andries C Bloem; Tuna Mutis; Sonja Zweegman; Niels W C J van de Donk
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

3.  Supportive care in multiple myeloma: Current practices and advances.

Authors:  Teresa S Miceli; Wilson I Gonsalves; Francis K Buadi
Journal:  Cancer Treat Res Commun       Date:  2021-10-09

Review 4.  Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Authors:  C T Rieger; B Liss; S Mellinghoff; D Buchheidt; O A Cornely; G Egerer; W J Heinz; M Hentrich; G Maschmeyer; K Mayer; M Sandherr; G Silling; A Ullmann; M J G T Vehreschild; M von Lilienfeld-Toal; H H Wolf; N Lehners
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

5.  VaccHemInf project: protocol for a prospective cohort study of efficacy, safety and characterisation of immune functional response to vaccinations in haematopoietic stem cell transplant recipients.

Authors:  Anne Conrad; Mathilde Boccard; Florent Valour; Vincent Alcazer; Aydee-Tamara Tovar Sanchez; Christian Chidiac; Frédéric Laurent; Philippe Vanhems; Gilles Salles; Karen Brengel-Pesce; Boris Meunier; Sophie Trouillet-Assant; Florence Ader
Journal:  BMJ Open       Date:  2019-02-15       Impact factor: 2.692

6.  Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy.

Authors:  Carla S Walti; Andrea N Loes; Kiel Shuey; Elizabeth M Krantz; Jim Boonyaratanakornkit; Jacob Keane-Candib; Tillie Loeffelholz; Caitlin R Wolf; Justin J Taylor; Rebecca A Gardner; Damian J Green; Andrew J Cowan; David G Maloney; Cameron J Turtle; Steven A Pergam; Helen Y Chu; Jesse D Bloom; Joshua A Hill
Journal:  medRxiv       Date:  2021-05-11

Review 7.  Influenza vaccines in immunosuppressed adults with cancer.

Authors:  Roni Bitterman; Noa Eliakim-Raz; Inbal Vinograd; Anca Zalmanovici Trestioreanu; Leonard Leibovici; Mical Paul
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01

Review 8.  Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Michel Delforge; Thierry Facon; Hermann Einsele; Francesca Gay; Philippe Moreau; Hervé Avet-Loiseau; Mario Boccadoro; Roman Hajek; Mohamad Mohty; Michele Cavo; Meletios A Dimopoulos; Jesús F San-Miguel; Evangelos Terpos; Sonja Zweegman; Laurent Garderet; María-Victoria Mateos; Gordon Cook; Xavier Leleu; Hartmut Goldschmidt; Graham Jackson; Martin Kaiser; Katja Weisel; Niels W C J van de Donk; Anders Waage; Meral Beksac; Ulf H Mellqvist; Monika Engelhardt; Jo Caers; Christoph Driessen; Joan Bladé; Pieter Sonneveld
Journal:  Leukemia       Date:  2018-05-02       Impact factor: 11.528

9.  COVID-19 and myeloma: what are the implications for now and in the future?

Authors:  Ciara L Freeman; Joseph Mikhael
Journal:  Br J Haematol       Date:  2020-06-25       Impact factor: 8.615

Review 10.  Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network.

Authors:  Heinz Ludwig; Mario Boccadoro; Philippe Moreau; Jesus San-Miguel; Michele Cavo; Charlotte Pawlyn; Sonja Zweegman; Thierry Facon; Christoph Driessen; Roman Hajek; Melitios A Dimopoulos; Francesca Gay; Hervé Avet-Loiseau; Evangelos Terpos; Niklas Zojer; Mohamad Mohty; Maria-Victoria Mateos; Hermann Einsele; Michel Delforge; Jo Caers; Katja Weisel; Graham Jackson; Laurent Garderet; Monika Engelhardt; Niels van de Donk; Xavier Leleu; Hartmut Goldschmidt; Meral Beksac; Inger Nijhof; Niels Abildgaard; Sara Bringhen; Pieter Sonneveld
Journal:  Leukemia       Date:  2020-08-19       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.